Lamivudine as initial treatment for chronic hepatitis B in the United States. [electronic resource]
Producer: 19991026Description: 1256-63 p. digitalISSN:- 0028-4793
- Adolescent
- Adult
- Aged
- Alanine Transaminase -- blood
- DNA, Viral -- blood
- Double-Blind Method
- Female
- Hepatitis B e Antigens -- blood
- Hepatitis B virus -- genetics
- Hepatitis B, Chronic -- blood
- Humans
- Lamivudine -- adverse effects
- Liver -- pathology
- Male
- Middle Aged
- Mutation
- Prospective Studies
- Reverse Transcriptase Inhibitors -- adverse effects
- United States
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.